Uchiyama, T.; Kobashi, Y.; Kawamura, T.; Nishikawa, Y.; Nakayama, A.; Oguro, F.; Kaneko, Y.; Yamamoto, C.; Ito, N.; Zhao, T.;
et al. Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study. Vaccines 2025, 13, 259.
https://doi.org/10.3390/vaccines13030259
AMA Style
Uchiyama T, Kobashi Y, Kawamura T, Nishikawa Y, Nakayama A, Oguro F, Kaneko Y, Yamamoto C, Ito N, Zhao T,
et al. Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study. Vaccines. 2025; 13(3):259.
https://doi.org/10.3390/vaccines13030259
Chicago/Turabian Style
Uchiyama, Taiga, Yurie Kobashi, Takeshi Kawamura, Yoshitaka Nishikawa, Aya Nakayama, Fumiya Oguro, Yudai Kaneko, Chika Yamamoto, Naomi Ito, Tianchen Zhao,
and et al. 2025. "Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study" Vaccines 13, no. 3: 259.
https://doi.org/10.3390/vaccines13030259
APA Style
Uchiyama, T., Kobashi, Y., Kawamura, T., Nishikawa, Y., Nakayama, A., Oguro, F., Kaneko, Y., Yamamoto, C., Ito, N., Zhao, T., Saito, H., Abe, T., Kodama, T., & Tsubokura, M.
(2025). Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study. Vaccines, 13(3), 259.
https://doi.org/10.3390/vaccines13030259
